Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Both of you are right really. Since the covid pill vaccine announcement its been downhill. From over 3 bucks to 63 cents. Not good. Awful actually. Im not so sure we have seen the bottom. I can see 50 cents coming. Maybe. At the same time aezs will be a big winner long term. We could easily hit 10 bucks on a couple of catalysts we have coming. I think aezs will be a big winner long term. The child test alone will have big sales as its for an unmet need. If covid becomes like the flu shot Aezs could theoretically makes some noise because the covid pill vaccine is different than the current options and the ease of the pill would help also. No injection . Again this is if covid becomes like the flu shot. Ive said all along the key was other uses for macrilen. Could be big especially with the 2 trials in usa. God bless all and good luck too
I’ll take that bet,
So wrong
Earliest progress report is next July! Not soon..
upcoming catalysts
1. COVID-19 Pill
2. AGHD-Adult Growth Hormone Deficiency
3. CGHD-Child Growth Hormone Deficiency
4. PTH-Parathyroid Hormone (PTH) fusion polypeptides.
5. NMOSD-Neuromyelities Optica Epectrum Disorder
6. NMOSD-Neurodegenerative disease announcement soon.
PILES OF CASH
they cant announce anything until its ready,remember what i told u about being down 90 plus % in aezs before and i ended up making money,again what will pps be when these catalysts for unmet needs come to fruition,it will push 10 bucks and more,we have to wait it out,God bless all and good luck 2
Very bad. AEZS management had not monitored the progress of product development one news after another so that share price is getting supported and pushed up. Good company has series of good news coming out one after one so that shareholders’ interest is being looked after. Here is not so, shareholders are exposed to shorters
long term u cant lose imo,wat too many different catalysts coming and more than 1 for unmet needs,it could get a little ugly till then but not much more than what has happened already,again what will pps be when pedi test is approved,same for the 2 phase 3 trials in usa for cancer cachexia and tbi,what will pps be if fda approves 1 or even both,the pps will skyrocketand eu and row will follow fda like they did the adult test and we own all of macrilen other uses except n america where novo owns the rights,still it will increase macrilen sales bigtime of which we get %,im telling u imo this will fly on these approvals,gain they are for unmet needs and thats not counting lou gehrigs disease and every other new licensing deaals aezs has,when i think the bottom is reached i will load the boat and wait it out till it hits
It is more than 9 months to go for next July! No catalysts news in-between. I am afraid COVID pill is of no use as news will only come in 2023/4. Rudel said it takes few months and now few years on next news.
agreed but in time is 6 months to a yr barring any suprise treats,still long term u cant not lose imo,again other uses for macrilen could be huge along with pedi approval which again is for an unmet need as are other things aezs has going,sometimes patience is everything,those that bought at 3 will make bank longterm,God bless all
no worries , in time we win AEZS
This company has been operating more than 30 years…many things too slow and losing competitive advantage!
I am afraid it is not about going down to 0.5, but RS, or going to pink and even delisted..
I am afraid no easy money. Progress too slow and value will be lost.
This is my fear also that it could go to 50 cents. I will load up if she goes down more. It’s easy money long term imo. God bless all
The next catalyst is by July 2022 if there is no delay. This we talk about 9-10 months! We most likely will face RS or even going to pink or delisted… very bad.
All good folks making coin , more powder on the way AEZS
yes and child test is for an unmet need$$$$
Soooo, since AEZS hasn't delayed or postponed any milestones, confirmed yesterday they're right on track with P3 DETECT trial, you're saying AEZS has good management. Nice!!! LOL
A good management will always meet their own milestones. Company delaying milestones is not a good management! Nearest milestone now postponed till 9 months later, very bad.
Still on track for July 2022 completion...
They already got the 5 mill from novo for that. It was when they adjusted the % of sales. Look it up. God bless all
A further $5 million will be paid if the FDA approves a pediatric indication for Macrilen, with Strongbridge funding 70% of the costs of a worldwide development program to make this happen.
Trial site updated. Enrolling, PR coming
https://clinicaltrials.gov/ct2/show/NCT04786873
$25-30M might be considered pathetic, but it's growing and it comes with a $4M milestone payment. At $40M, AEZS licensing revenue % increases to 15% for sales over $40M. At $50M, they get a $10M milestone payment. I believe we're going to get that $25M milestone payment this year setting up 2022 to be a really big year with sales climbing and P3 DETECT completion with successful results.... I'm still a buyer....
Macrilen sales is pathetic, far below expectation and very bad for this only product which is selling..
What??? Zero revenue??? LOL Keep'em coming.... LOL
they want 3500 for a puppy for mom , lets go AEZS
:) we r ok , if we hit 50 buy the heck out of it AEZS
its getting very interesting , very cheap pps AEZS
keep up champ Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced the closing of its previously announced public offering of 20,509,746 common shares of Aeterna, at a price to the public of $1.45 per share. The gross proceeds from the offering were approximately $29.7 million, before deducting underwriting discounts, commissions and offering expenses payable by Aeterna.
Lol spuds is the only shareholder it seems! Lol
This is going to pink, or a huge RS
Value? What value? This is a speculative biotech with zero revenue, a share price almost 50% below nasdaq requirements that most likely with necessitate a massive reverse split to maintain their listing. Otherwise, the ONLY way this continues to trade is on the pinkies list.
So… what value are you referring to?
dam 35 RSI geez la weez , maybe take a bite AEZS
u were smart but now u can take advantage when u r ready , whats the RSI at?
on the bottom of the ocean with block boots , someone bring me some air , AEZS is hold. I'm good... buying CLOV big time all will work out , revenues r increasing , we have time , I can wait and buy all day long , no problem
nice congrats , I'm holding off , will hold and will buy more later... AEZS
SWEET BABY JESUS AEZS
long term u are right meaning 6 months or more imo or right before delisting ,im sure we will get something,thats 3 months away however,in the end u will be right imo because aezs is set up for success with a low burn rate ,money in bank to last 2 more yrs, 68 mill i think rt now,and multiple different catalysts coming,some for unmet medical needs,its going to be a long 3-6 months though and this drop to 60 cents absolutely sucks,God bless all
Got $.58s today.
The value is insane.
I agree but other uses for macrilen and pedi test will be way more
Yup, they could go cash revenue positive next qtr.
Revenue is up 700% last qtr.
I've said from the beginning it's about Macrilen sales and that's why I'm here. I have never hoped or believed in the quick COVID vaccine fantasy nor did I hear anything from AEZS that made me think that a oral vaccine pill wasn't years away. I would be happy with a COVID vaccine pump to $12 though...LOL
I have absolutely, and wrongly I might add, believed Macrilen sales would come faster and bigger, but Macrilen sales ARE picking up and it's looking like they're headed for around $25-30M this year. $13M so far... $40M in sales is the magic number. If sales growth continues, we'll hit that next year for sure. I see no upside in share price without some other positive news or until people start to believe Macrilen sales will pay the bills... Or another "miracle coming" pump and dump...LOL
Agree. AEZS is very BAD! A company with only 11 employees and we are hoping this company has miracle coming down!
Followers
|
301
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
18784
|
Created
|
05/09/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |